Negative allosteric regulation of protein arginine methyltransferase 1 (PRMT1) through half-of-sites reactivity

Vincent Z. Rossi, Robert S. Wilson-Kovacs, Yuan Gao, Caroline Velez, Sofiia Hakh, Chao Xue, Jun Qu, Vicki Wysocki, Orlando Acevedo, Joan M. Hevel · 2026

Read Negative allosteric regulation of protein arginine methyltransferase 1 (PRMT1) through half-of-sites reactivity by Vincent Z. Rossi, Robert S. Wilson-Kovacs, Yuan Gao, Caroline Velez, Sofiia Hakh, Chao Xue, Jun Qu, Vicki Wysocki, Orlando Acevedo, Joan M. Hevel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571421.txt.

Description

Protein arginine methyltransferase 1 (PRMT1) activity is essential for maintaining proper eukaryotic cellular function; however, its dysregulation contributes to the progression of several human diseases and cancers, making PRMT1 an attractive therapeutic target. Efforts to inhibit PRMT1 through active-site-directed competitive strategies have faced significant challenges, highlighting the need to discover and exploit allosteric regulatory mechanisms.

Catalog record

CREATORVincent Z. Rossi, Robert S. Wilson-Kovacs, Yuan Gao, Caroline Velez, Sofiia Hakh, Chao Xue, Jun Qu, Vicki Wysocki, Orlando Acevedo, Joan M. Hevel
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13571421

Browse the full library · About the Tower of Babel